BioTime rebrands as Lineage Cell Therapeutics

BioTime has changed its name to Lineage Cell Therapeutics to better reflect its commitment to becoming a leading cell therapy company, according to a press release.

“It has been less than 1 year since I joined the company, and I’m excited that we have largely completed the strategic and multifaceted plan to simplify our business structure and reposition ourselves as one of the most promising and focused cell therapy companies,” Brian M. Culley, the company’s CEO, said in the release

Lineage Cell Therapeutics’ NYSE American ticker symbol is LCTX, and the company has relocated its corporate headquarters to Carlsbad, California.

“We look forward to inviting stakeholders to rediscover what sets us apart from other companies and to join us as we embark on the next step of this exciting journey. Control the lineage of cells; don’t leave it up to fate,” Culley said.

BioTime has changed its name to Lineage Cell Therapeutics to better reflect its commitment to becoming a leading cell therapy company, according to a press release.

“It has been less than 1 year since I joined the company, and I’m excited that we have largely completed the strategic and multifaceted plan to simplify our business structure and reposition ourselves as one of the most promising and focused cell therapy companies,” Brian M. Culley, the company’s CEO, said in the release

Lineage Cell Therapeutics’ NYSE American ticker symbol is LCTX, and the company has relocated its corporate headquarters to Carlsbad, California.

“We look forward to inviting stakeholders to rediscover what sets us apart from other companies and to join us as we embark on the next step of this exciting journey. Control the lineage of cells; don’t leave it up to fate,” Culley said.